CRUSEKITUG

UNII:	6YYC67U8QJ
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	CRUSEKITUG
GSRS Full Record:	6YYC67U8QJ i

2956768-50-4
Crusekitug
H-gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV4-4*08 (79.4%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT [8.7.14] (26-33.51-57.96-109)) (1-120) -Homo sapiens IGHG1*01 (100%) G1m17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-217')-disulfide with L-kappa light chain humanized (1'-217') [VKAPPA (Homo sapiens IGKV1-12*01 (89.2%) -IGKJ4*01 (91.7%), CDR-IMGT [6.3.12] (27'-32'.50'-52'.89'-100')) (1'-110') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (156'), V101 (194')) (111'-217')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-S, glycoform alfa
Immunoglobulin G1, anti-(human interleukin 17A) (human-Oryctolagus cuniculus monoclonal QX002N γ1-chain), disulfide with human-Oryctolagus cuniculus monoclonal QX002N κ-chain, dimer
QX-002N
QX002N
crusekitug [INN]
immunoglobulin G1-kappa, anti-[Homo sapiens IL17A (interleukin 17A, IL-17A)], humanized monoclonal antibody

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CRUSEKITUG

Synonyms and Mappings

Resources